Fennec Pharmaceuticals Inc.  (FENCF)
Other Ticker:  
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 26
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 0

Fennec Pharmaceuticals Inc.

   Company Address: PO Box 13628, 68 TW Alexander Drive Research Triangle Park 27709 NC
   Company Phone Number: 636-4530   Stock Exchange / Ticker: NASDAQ FENCF
   FENCF is expected to report next financial results on November 09, 2022.


Stock Performances by Major Competitors

Year to Date Decrease / Increase
• View Complete Report

Best Buy Co. inc.

EPS Drops by Best Buy Co. Inc in the fiscal time-frame ending Jul 30 2022 release

In the fiscal time-frame ending Jul 30 2022 company reported soft top and bottom-line results, where earnings per share plummeted by -53.45 % and revenue by -12.83% year on year. Revenue were to $10.33 billions compared to $11.85 billions eps at $1.35 compared to $2.90 in same quarter a year ago.

Buckle Inc

Buckle Inc announced that Sales went up modestly in the second quarter of 2022

Sales growth of 2.32%, could not prevent income contraction of -2.88 % in the second quarter of 2022, compared to same quarter a year ago. Sales were at $301.98 millions and eps at $1.01.

Genesco Inc

Deterioration in Earnings by Genesco Inc in the most recent fiscal period statement

Genesco Inc reported soft results for the most recent fiscal period, where income fell by -21.33 % to $0.59 per share and Sales decreased by -3.58% to $535.33 millions, year on year.

Cisco Systems Inc.

Cisco Systems Inc disclosed fourth quarter of 2022 operating income of $3434 millions

Cisco Systems Inc announced disappointing results, eps deteriorated by -4.69 % to $0.68 from $0.71 and Sales declined by -0.18% to $13.10 billions in the fourth quarter of 2022, year on year.

Mei Pharma Inc.

Deficit Widen by Mei Pharma Inc in the fourth quarter of 2022 announcement

In the fourth quarter of 2022 Mei Pharma Inc posted a loss of $-0.13 per share compared to $0.03 a year ago and increased losses from $-0.07 per share from the previous quarter.



Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SKYA's Profile

Stock Price

SKYA's Financials

Business Description


Charts & Quotes

SKYA's News


SKYA's Competitors

Customers & Markets

Economic Indicators

SKYA's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071